Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsing-Remitting Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04260711
What this trial is testing

Discontinuing Disease-modifying Therapies in Stable Relapsing - Onset Multiple Sclerosis (DOT-MS).

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary Progressive
Amsterdam UMC, location VUmc 130
Testing effectiveness (Phase 2)UnknownNCT00298662
What this trial is testing

Combination Therapy of Betaseron-Prograf in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Clinique de sclérose en plaques et neuromusculaire de l'Outaouais 30
Not applicableStudy completedNCT06987994
What this trial is testing

The Effect of Virtual Reality on Fatigue and Functional Capacity in Patients With MS

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingVirtual Reality
Istinye University 30
Early research (Phase 1)Study completedNCT02506751
What this trial is testing

Open-label Study of Liothyronine in MS

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Primary Progressive
Johns Hopkins University 20
Not applicableStudy completedNCT02403570
What this trial is testing

Rotating Frame Relaxation Imaging in Patients With Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic Progressive
Turku University Hospital 21
Post-approval studies (Phase 4)Study completedNCT01142466
What this trial is testing

A Phase IV Study of Rebif ® 44mcg Administered Three Times Per Week by Subcutaneous Injection Compared With no Treatment in the Therapy of Relapsing Multiple Sclerosis After Mitoxantrone

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Merck KGaA, Darmstadt, Germany 30
Early research (Phase 1)Ended earlyNCT01435993
What this trial is testing

Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GlaxoSmithKline 3
Testing effectiveness (Phase 2)Study completedNCT01185821
What this trial is testing

Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Novartis Pharmaceuticals 185
Post-approval studies (Phase 4)Ended earlyNCT02901106
What this trial is testing

Monitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarate

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Fondation Ophtalmologique Adolphe de Rothschild 11
Early research (Phase 1)Study completedNCT04570670
What this trial is testing

Comparative Bioavailability of BAFIERTAM™ (Monomethyl Fumarate) and Tecfidera® (Dimethyl Fumarate) in Healthy Subjects

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Banner Life Sciences LLC 50
Not applicableStudy completedNCT03134573
What this trial is testing

Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot Study

Who this might be right for
Multiple Sclerosis
Bayer 96
Testing effectiveness (Phase 2)Study completedNCT00382629
What this trial is testing

BHT-3009 Immunotherapy in Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Bayhill Therapeutics 252
Not applicableStudy completedNCT07000968
What this trial is testing

The Effect of Task-Oriented Training and Virtual Reality Training on Balance, Gait and Fatigue in Individuals With Multiple Sclerosis

Who this might be right for
Multiple SclerosisBalance Impairment, Gait Disorders, FatigueMultiple Sclerosis Bening+1 more
Inonu University 63
Not applicableStudy completedNCT02696590
What this trial is testing

High Dose Oral Versus Intramuscular Vitamin D3 Supplementation In Multiple Sclerosis Patients

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Isfahan University of Medical Sciences 200
Not applicableStudy completedNCT03975413
What this trial is testing

Fecal Microbiota Transplantation (FMT) in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Rush University Medical Center 1
Not applicableUnknownNCT05277740
What this trial is testing

Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple Sclerosis

Who this might be right for
Clinically Isolated SyndromeRelapsing Remitting Multiple Sclerosis
McGill University 120
Post-approval studies (Phase 4)Ended earlyNCT01436643
What this trial is testing

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Who this might be right for
DepressionRelapsing-remitting Multiple Sclerosis
Novartis Pharmaceuticals 54
Early research (Phase 1)Not Yet RecruitingNCT07562074
What this trial is testing

Transcranial Magnetic Stimulation for Depression in Multiple Sclerosis

Who this might be right for
Multiple SclerosisDepression - Major Depressive DisorderFatigue
University of Calgary 20
Not applicableStudy completedNCT07346924
What this trial is testing

Effect of Probiotics on Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS) Relapsing Remitting
Cairo University 60
Testing effectiveness (Phase 2)Study completedNCT01742052
What this trial is testing

Dose-finding Study of MT-1303

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Tanabe Pharma Corporation 415
Next Page